Pyrazinamide market
Pyrazinamide Market, by Patient Type (Adult and Pediatric), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
- Dec 2020
- CMI4317
- 149 Pages
- Excel & Pdf
- Pharmaceutical
The increasing tuberculosis (TB) disease prevalence is a major factor that is expected to drive growth of the global pyrazinamide market. For instance, according to the National Center for Biotechnology Information in 2019, total 8,920 number of TB disease new cases were provisionally reported in the U.S. according to same source, the rate of TB is around 2.7 per 100,000 persons. Moreover, TB is a major burden across the globe. According to TB Facts report organization data, in 2018, in the U.S, the cost of treating drug sensitive TB was US$ 49,000; treatment costs for MDR-TB averaged US$ 393,000; and treatment costs for XDR TB averaged US$ 758,000.
Global Pyrazinamide Market - Impact of Coronavirus (COVID-19) Pandemic
The spread of the novel coronavirus has hampered growth of the healthcare industry. In December 2019, a cluster of pneumonia cases were reported by Chinese health authorities in China’s Wuhan City. The pneumonia causative agent was identified as a novel coronavirus named COVID-19. This virus spread rapidly across the globe causing a concerning number of fatalities. In March, 2020, the World Health Organization (WHO) declared COVID-19 as a global pandemic and suggested implementation of strict measures to minimize the spread of this disease. The pandemic has slowed growth of the healthcare sector and led to a disturbance in the supply chain of pharmaceutical drugs.
Moreover, governments across various countries have implemented nationwide lockdowns to curb the spread of COVID-19. Similarly, in various countries across the world, healthcare companies are facing problems of continuing their supply chain operations. The slowdown of the supply chain has also impacted growth of the global pyrazinamide market.
The global pyrazinamide market is estimated to be valued at US$ 143.9 million in 2020 and is expected to exhibit a CAGR of 4.6% during the forecast period (2020-2027).
Fig. 1. Global Pyrazinamide Market Share (%) Analysis, By Patient Type, 2020
Global Pyrazinamide Market- Restraints
Increasing pyrazinamide drug resistant TB infection is a major factor that is expected to restrain growth of the global pyrazinamide market.
Pyrazinamide Market Report Coverage
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2019 | Market Size in 2020: | US$ 143.9 Mn |
Historical Data for: | 2017 to 2019 | Forecast Period: | 2020 to 2027 |
Forecast Period 2020 to 2027 CAGR: | 4.6% | 2027 Value Projection: | US$ 163.1 Mn |
Geographies covered: |
|
||
Segments covered: |
|
||
Companies covered: |
Pure Chemistry Scientific, LGM Pharma, TCI, HBCChem, Alfa Chemistry, Toronto Research Chemicals, Acros Organics, AlliChem, Waterstone Technology, City Chemical, EDQM, J & K SCIENTIFIC, Meryer (Shanghai) Chemical Technology, Energy Chemical, and Beijing Ouhe Technology. |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Global Pyrazinamide Market: Regional Analysis
On the basis of region, the global pyrazinamide market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to witness significant growth in the global pyrazinamide market, owing to increasing number of TB patient across the U.S. and Canada respectively. For instance, in 2019, according to data of the Centers for Disease Control and Prevention states that, around 8,916 number of TB cases were reported in the U.S. Similarly, in 2017, according to the Canada government data, there were around 1,796 number of TB cases reported in Canada, when compared with around 1,750 number of TB cases in 2016, indicates a 2.6% increase.
Additionally, in Europe, growth of the pyrazinamide market is attributed to high number of TB patients. For instance, according to European Centre for Disease Prevention and Control data around 55,337 TB cases were reported in year 2017, which was around rate of 10.7 per 100,000 population.
Fig.2. Global Pyrazinamide Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Global Pyrazinamide Market- Competitive Landscape
Key players operating in the global pyrazinamide market include Pure Chemistry Scientific, LGM Pharma, TCI, HBCChem, Alfa Chemistry, Toronto Research Chemicals, Acros Organics, AlliChem, Waterstone Technology, and, City Chemical.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Patient Type
- Market Snapshot, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Key Developments
- Impact Analysis
- Mergers & Acquisitions
- New Product Launch
- Technology Overview
- PEST Analysis
- Market Dynamics
- Global Pyrazinamide Market - Impact of Coronavirus (Covid-19) Pandemic
- COVID 19 Impact Analysis
- New Developments
- Global Pyrazinamide Market, By Patient Type, 2016 – 2027, (US$ million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Pyrazinamide Market, By Distribution Channel, 2016 – 2027, (US$ million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Pyrazinamide Market, By Region, 2016– 2027, (US$ Million)
- Introduction
- Market Share Analysis, By Patient Type, 2020 and 2027 (%)
- Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, By Region, 2017 – 2027
- Regional Trends
- North America
- Market Share Analysis, By Patient Type, 2020 and 2027 (%)
- Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.S.
- Canada
- Europe
- Market Share Analysis, By Patient Type, 2020 and 2027 (%)
- Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Share Analysis, By Patient Type, 2020 and 2027 (%)
- Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Share Analysis, By Patient Type, 2020 and 2027 (%)
- Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Share Analysis, By Patient Type, 2020 and 2027 (%)
- Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Share Analysis, By Patient Type, 2020 and 2027 (%)
- Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Pure Chemistry Scientific
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- LGM Pharma
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- City Chemical
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- TCI
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- HBCChem
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Alfa Chemistry
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Toronto Research Chemicals
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Acros Organics
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- AlliChem
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Waterstone Technology
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pure Chemistry Scientific
- Company Profiles
- Section
- References
- Research Methodology
- About Us and Sales Contact
*Browse 28 market data tables and 25 figures on "Global Pyrazinamide Market” - Forecast to 2027”